Consultation on the regulatory framework for subsequent entry biologics : summary report, June 5-6, 2008, Chateau Cartier, Aylmer, Quebec / Health Canada, Centre for Policy and Regulatory Affairs, Biologic...: H14-474/2008E-PDF
"In twelve hours of meetings over two days in early June 2008, 105 government and stakeholder representatives enjoyed the opportunity to exchange information and views with regard to Subsequent Entry Biologic products (SEBs). A series of presentations were followed by intensive table discussions around the key issues, including fundamental concepts, quality requirements, clinical requirements, intellectual property, comparability, and post-market measures"--Consultation summary, page 3.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.931618&sl=0
| Department/Agency |
|
|---|---|
| Title | Consultation on the regulatory framework for subsequent entry biologics : summary report, June 5-6, 2008, Chateau Cartier, Aylmer, Quebec / Health Canada, Centre for Policy and Regulatory Affairs, Biologic and Genetic Therapies Directorate. |
| Variant title |
|
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (22 pages) |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: